As a result, SOD1 protein levels in spinal cord tissue were lower than corresponding levels in untreated patients with SOD1-mediated ALS and in healthy controls, showing that gene silencing-therapy could be used as a potential treatment for familial ALS40,.41 Here, SOD1 is linked to amyotrophic lateral sclerosis.